|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ho C, Wang C, Mattu S, Destefanis G, Ladu
S, Delogu S, Armbruster J, Fan L, Lee SA, Jiang L, et al: AKT
(v-akt murine thymoma viral oncogene homolog 1) and N-Ras
(neuroblastoma ras viral oncogene homolog) coactivation in the
mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian
target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and
c-Myc pathways. Hepatology. 55:833–845. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wu Y, Cain-Hom C, Choy L, Hagenbeek TJ, de
Leon GP, Chen Y, Finkle D, Venook R, Wu X, Ridgway J, et al:
Therapeutic antibody targeting of individual Notch receptors.
Nature. 464:1052–1057. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Han D, Li J, Wang H, Su X, Hou J, Gu Y,
Qian C, Lin Y, Liu X, Huang M, et al: Circular RNA MTO1 acts as the
sponge of miR-9 to suppress hepatocellular carcinoma progression.
Hepatology. 66:1151–1164. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Manikandan J, Aarthi JJ, Kumar SD and
Pushparaj PN: Oncomirs: The potential role of non-coding microRNAs
in understanding cancer. Bioinformation. 2:330–334. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Simon DJ, Madison JM, Conery AL,
Thompson-Peer KL, Soskis M, Ruvkun GB, Kaplan JM and Kim JK: The
microRNA miR-1 regulates a MEF-2-dependent retrograde signal at
neuromuscular junctions. Cell. 133:903–915. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yates LA, Norbury CJ and Gilbert RJ: The
long and short of microRNA. Cell. 153:516–519. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hoffend NC, Magner WJ and Tomasi TB: The
epigenetic regulation of Dicer and microRNA biogenesis by
Panobinostat. Epigenetics. 12:105–112. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fang F, Chang RM, Yu L, Lei X, Xiao S,
Yang H and Yang LY: MicroRNA-188-5p suppresses tumor cell
proliferation and metastasis by directly targeting FGF5 in
hepatocellular carcinoma. J Hepatol. 63:874–885. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang H, Liu H and Bi H: MicroRNA-345
inhibits hepatocellular carcinoma metastasis by inhibiting YAP1.
Oncol Rep. 38:843–849. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chang RM, Xiao S, Lei X, Yang H, Fang F
and Yang LY: miRNA-487a promotes proliferation and metastasis in
hepatocellular carcinoma. Clin Cancer Res. 23:2593–2604. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Makki N and Capecchi MR: Cardiovascular
defects in a mouse model of HOXA1 syndrome. Hum Mol Genet.
21:26–31. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yuan C, Zhu X, Han Y, Song C, Liu C, Lu S,
Zhang M, Yu F, Peng Z and Zhou C: Elevated HOXA1 expression
correlates with accelerated tumor cell proliferation and poor
prognosis in gastric cancer partly via cyclin D1. J Exp Clin Cancer
Res. 35:152016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xiao F, Bai Y, Chen Z, Li Y, Luo L, Huang
J, Yang J, Liao H and Guo L: Downregulation of HOXA1 gene affects
small cell lung cancer cell survival and chemoresistance under the
regulation of miR-100. Eur J Cancer. 50:1541–1554. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bitu CC, Destro MF, Carrera M, da Silva
SD, Graner E, Kowalski LP, Soares FA and Coletta RD: HOXA1 is
overexpressed in oral squamous cell carcinomas and its expression
is correlated with poor prognosis. BMC Cancer. 12:1462012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang H, Liu G, Shen D, Ye H, Huang J, Jiao
L and Sun Y: HOXA1 enhances the cell proliferation, invasion and
metastasis of prostate cancer cells. Oncol Rep. 34:1203–1210. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Llovet JM, Villanueva A, Lachenmayer A and
Finn RS: Advances in targeted therapies for hepatocellular
carcinoma in the genomic era. Nat Rev Clin Oncol. 12:408–424. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gumireddy K, Li A, Cao L, Yan J, Liu L, Xu
X, Pazoles C and Huang Q: NOV-002, a glutathione disulfide mimetic,
suppresses tumor cell invasion and metastasis. J Carcinog Mutagen.
2013:S7–002. 2013.PubMed/NCBI
|
|
20
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev Cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hummel R, Hussey DJ and Haier J:
MicroRNAs: Predictors and modifiers of chemo- and radiotherapy in
different tumour types. Eur J Cancer. 46:298–311. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tao Z, Zhao H, Wang R, Liu P, Yan F, Zhang
C, Ji X and Luo Y: Neuroprotective effect of microRNA-99a against
focal cerebral ischemia-reperfusion injury in mice. J Neurol Sci.
355:113–119. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lin KY, Ye H, Han BW, Wang WT, Wei PP, He
B, Li XJ and Chen YQ: Genome-wide screen identified
let-7c/miR-99a/miR-125b regulating tumor progression and stem-like
properties in cholangiocarcinoma. Oncogene. 35:3376–3386. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang Z, Han Y, Cheng K, Zhang G and Wang
X: miR-99a directly targets the mTOR signalling pathway in breast
cancer side population cells. Cell Prolif. 47:587–595. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang HG, Luo X, Wu S and Jian B: MiR-99a
inhibits cell proliferation and tumorigenesis through targeting
mTOR in human anaplastic thyroid cancer. Asian Pac J Cancer Prev.
16:4937–4944. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li Q, Zhang X, Li N, Liu Q and Chen D:
miR-30b inhibits cancer cell growth, migration, and invasion by
targeting homeobox A1 in esophageal cancer. Biochem Biophys Res
Commun. 485:506–512. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
López-Romero R, Marrero-Rodríguez D,
Romero-Morelos P, Villegas V, Valdivia A, Arreola H, Huerta-Padilla
V and Salcedo M: The role of developmental HOX genes in cervical
cancer. Rev Med Inst Mex Seguro Soc. 53 (Suppl 2):S188–S193.
2015.(In Spanish). PubMed/NCBI
|
|
28
|
Ohuchida K, Mizumoto K, Lin C, Yamaguchi
H, Ohtsuka T, Sato N, Toma H, Nakamura M, Nagai E, Hashizume M, et
al: MicroRNA-10a is overexpressed in human pancreatic cancer and
involved in its invasiveness partially via suppression of the HOXA1
gene. Ann Surg Oncol. 19:2394–2402. 2012. View Article : Google Scholar : PubMed/NCBI
|
